Sarcoma, Ewing

"Sarcoma, Ewing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.

Descriptor ID	D012512
MeSH Number(s)	C04.557.450.565.575.650.800 C04.557.450.795.620.800
Concept/Terms	Sarcoma, Ewing Sarcoma, Ewing Sarcoma, Ewing's Sarcoma, Ewings Ewing's Sarcoma Ewings Sarcoma Ewing's Tumor Ewings Tumor Tumor, Ewing's Ewing Sarcoma Ewing Tumor Tumor, Ewing

Below are MeSH descriptors whose meaning is more general than "Sarcoma, Ewing".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Connective and Soft Tissue [C04.557.450]
Neoplasms, Connective Tissue [C04.557.450.565]
Neoplasms, Bone Tissue [C04.557.450.565.575]
Osteosarcoma [C04.557.450.565.575.650]
Sarcoma, Ewing [C04.557.450.565.575.650.800]
Sarcoma [C04.557.450.795]
Osteosarcoma [C04.557.450.795.620]
Sarcoma, Ewing [C04.557.450.795.620.800]

Below are MeSH descriptors whose meaning is related to "Sarcoma, Ewing".

Below are MeSH descriptors whose meaning is more specific than "Sarcoma, Ewing".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Sarcoma, Ewing" by people in this website by year, and whether "Sarcoma, Ewing" was a major or minor topic of these publications.

Bar chart showing 192 publications over 31 distinct years, with a maximum of 11 publications in 2007 and 2008 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	1	1	2
1993	1	0	1
1994	2	1	3
1995	1	0	1
1996	4	3	7
1997	0	1	1
1998	2	2	4
1999	2	1	3
2000	2	2	4
2001	3	3	6
2002	3	3	6
2003	3	1	4
2004	1	1	2
2005	8	1	9
2006	3	1	4
2007	9	2	11
2008	9	2	11
2009	6	2	8
2010	7	3	10
2011	8	1	9
2012	5	3	8
2013	8	1	9
2014	6	3	9
2015	7	2	9
2016	6	1	7
2017	8	3	11
2018	7	1	8
2019	7	2	9
2020	6	2	8
2021	4	0	4
2022	4	0	4

Below are the most recent publications written about "Sarcoma, Ewing" by people in Profiles.

Subbiah V, Braña I, Longhi A, Boni V, Delord JP, Awada A, Boudou-Rouquette P, Sarantopoulos J, Shapiro GI, Elias A, Ratan R, Fernandez C, Kahatt C, Cullell-Young M, Siguero M, Zeaiter A, Chawla SP. Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study. Clin Cancer Res. 2022 07 01; 28(13):2762-2770.

View in: PubMed
French CA, Cheng ML, Hanna GJ, DuBois SG, Chau NG, Hann CL, Storck S, Salgia R, Trucco M, Tseng J, Stathis A, Piekarz R, Lauer UM, Massard C, Bennett K, Coker S, Tontsch-Grunt U, Sos ML, Liao S, Wu CJ, Polyak K, Piha-Paul SA, Shapiro GI. Report of the First International Symposium on NUT Carcinoma. Clin Cancer Res. 2022 06 13; 28(12):2493-2505.

View in: PubMed
Wright A, Desai M, Bolan CW, Badawy M, Guccione J, Rao Korivi B, Pickhardt PJ, Mellnick VM, Lubner MG, Chen L, Elsayes KM. Extraskeletal Ewing Sarcoma from Head to Toe: Multimodality Imaging Review. Radiographics. 2022 Jul-Aug; 42(4):1145-1160.

View in: PubMed
Zhang N, Lin KF, Yang C, Peruski S, Pati D, Gilbertson SR. Synthesis and Evaluation of a Class of Compounds Inhibiting the Growth of Stromal Antigen 2 (STAG2)-Mutant Ewing Sarcoma Cells. ChemMedChem. 2022 05 04; 17(9):e202100653.

View in: PubMed
Koka K, Rahim FE, El-Hadad C, Bell D, Debnam JM, Guo Y, Esmaeli B. Primary Ewing's sarcoma with orbit involvement: Survival and visual outcomes after eye-sparing multidisciplinary management in eight patients. Head Neck. 2021 12; 43(12):3857-3865.

View in: PubMed
Collier AB, Krailo MD, Dang HM, DuBois SG, Hawkins DS, Bernstein ML, Bomgaars LR, Reed DR, Gorlick RG, Janeway KA. Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021 12; 68(12):e29333.

View in: PubMed
Ludwig JA, Meyers PA, Dirksen U. Ewing's Sarcoma. N Engl J Med. 2021 Apr 15; 384(15):1476.

View in: PubMed
Qasim SL, Sierra L, Shuck R, Kurenbekova L, Patel TD, Rajapakshe K, Wulff J, Nakahata K, Kim HR, Landesman Y, Unger TJ, Coarfa C, Yustein JT. p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma. Oncogene. 2021 02; 40(6):1176-1190.

View in: PubMed
Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist. 2021 03; 26(3):250-260.

View in: PubMed
Chugh R, Ballman KV, Helman LJ, Patel S, Whelan JS, Widemann B, Lu Y, Hawkins DS, Mascarenhas L, Glod JW, Ji J, Zhang Y, Reinke D, Strauss SJ. SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma. Cancer. 2021 04 15; 127(8):1301-1310.

View in: PubMed

People

Explore

Similar Concepts

Top Journals